メニュー 戻るLS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
19th DIA Japan Annual Meeting 2022
LS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?
Kayoko Kikuchi, PhD
- Chief, Unit of Project Management, Clinical Research Center
- National Center For Child Health and Development, Japan
Hidefumi Nakamura, MD, PhD
- Director for Clinical R&D,
- National Center for Child Health and Development, Japan
Miyako Matsumizu, MPharm
- Pfizer R&D Japan G.K., Japan
- Ministry of Health, Labour and Welfare (MHLW), Japan
- Child Life Specialist
- Toho University Omori Medical Center, Japan